67
Participants
Start Date
February 2, 2011
Primary Completion Date
October 18, 2011
Study Completion Date
October 18, 2011
Brodalumab
Administered intravenously once every 4 weeks
Research Site, Bonheiden
Research Site, Leuven
Research Site, Fitzroy
Research Site, Box Hill
Research Site, Kurralta Park
Research Site, Fremantle
Research Site, Roeselare
Research Site, Ghent
Research Site, Great Neck
Research Site, Chevy Chase
Research Site, Charlotte
Research Site, Toulouse
Research Site, Jacksonville
Research Site, Birmingham
Research Site, Pontevedra
Research Site, Nashville
Research Site, Vandœuvre-lès-Nancy
Research Site, Rochester
Research Site, Lille
Research Site, Mexico
Research Site, Hammond
Research Site, Paris
Research Site, Paris
Research Site, San Antonio
Research Site, Ogden
Research Site, Vancouver
Research Site, Winnipeg
Research Site, Hamilton
Research Site, Montreal
Research Site, Nice
Research Site, Amsterdam
Research Site, Bydgoszcz
Research Site, Sopot
Research Site, Barcelona
Lead Sponsor
Amgen
INDUSTRY